Well, I think, you know, a lot of the industry players that frankly benefit from the current system spend a lot of money on lobbying. I mean, the Lobbying disclosures are all public information. People can see, you know, how much is spent at the end of each session. And there's a lot of money spent by the various actors and the various players in the prescription drug supply chain to make sure that changes aren't made. (49:57–50:01)
CLAIM
Asserts that lobbying disclosures are publicly accessible.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
